Smad3 signaling activates bone marrow-derived fibroblasts in renal fibrosis

Laboratory Investigation

Volumn 94, Issue 5, 2014, Pages 545-556

  Chen, Jiyuan ^a   Xia, Yunfeng ^a   Lin, Xia ^a   Feng, Xin Hua ^a   Wang, Yanlin ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

bone marrow derived cells; chronic kidney disease; cytokine; extracellular matrix; fibroblasts; renal fibrosis

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN; SCLEROPROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; BIOACCUMULATION; BONE MARROW CELL; CELL ACTIVATION; FIBROBLAST; GENE DELETION; IN VITRO STUDY; KIDNEY FIBROSIS; KIDNEY INJURY; MONOCYTE; MOUSE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; URETER OBSTRUCTION;

ANIMALS; BONE MARROW CELLS; DISEASE MODELS, ANIMAL; FIBROBLASTS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOCYTES; NEPHROSCLEROSIS; SIGNAL TRANSDUCTION; SMAD3 PROTEIN;

EID: 84899525682     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2014.43     Document Type: Article

References (41)

1. Schainuck LI, Striker GE, Cutler RE, et al. Structural-functional correlations in renal disease. II. The correlations. Hum Pathol 1970;1 631-641.
2. Nath KA. The tubulointerstitium in progressive renal disease. Kidney Int 1998;54:992-994.
3. Eddy AA. Molecular basis of renal fibrosis. Pediatr Nephrol 2000; 15:290-301.
4. Neilson EG. Mechanisms of disease: fibroblasts-a new look at an old problem. Nat Clin Pract Nephrol 2006;2:101-108.
5. Strutz F, Muller GA. Renal fibrosis and the origin of the renal fibroblast. Nephrol Dial Transplant 2006;21:3368-3370.
6. Iwano M, Plieth D, Danoff TM, et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002;110:341-350.
7. Li J, Deane JA, Campanale NV, et al. The contribution of bone marrowderived cells to the development of renal interstitial fibrosis. Stem Cells 2007;25:697-706.
8. Sakai N, Wada T, Yokoyama H, et al. Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis. Proc Natl Acad Sci USA 2006;103:14098-14103.
9. Grimm PC, Nickerson P, Jeffery J, et al. Neointimal and tubulointerstitial infiltration by recipient mesenchymal cells in chronic renalallograft rejection. N Engl J Med 2001;345:93-97.
10. Broekema M, Harmsen MC, van Luyn MJ, et al. Bone marrow-derived myofibroblasts contribute to the renal interstitial myofibroblast population and produce procollagen I after ischemia/reperfusion in rats. J Am Soc Nephrol 2007;18:165-175.
11. Chen G, Lin SC, Chen J, et al. CXCL16 recruits bone marrow-derived fibroblast precursors in renal fibrosis. J Am Soc Nephrol 2011;22: 1876-1886.
12. Yang J, Lin SC, Chen G, et al. Adiponectin promotes monocyte-tofibroblast transition in renal fibrosis. J Am Soc Nephrol 2013;24: 1644-1659.
13. Bucala R, Spiegel LA, Chesney J, et al. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1994;1:71-81.
14. Niedermeier M, Reich B, Rodriguez Gomez M, et al. CD4\+ T cells control the differentiation of Gr1\+ monocytes into fibrocytes. Proc Natl Acad Sci USA 2009;106:17892-17897.
15. Shao DD, Suresh R, Vakil V, et al. Pivotal advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation. J Leukocyte Biol 2008;83:1323-1333.
16. Xia Y, Entman ML, Wang Y. Critical role of CXCL16 in hypertensive kidney injury and fibrosis. Hypertension 2013;62:1129-1137.
17. Metz CN. Fibrocytes: a unique cell population implicated in wound healing. Cell Mol Life Sci 2003;60:1342-1350.
18. Quan TE, Cowper S, Wu SP, et al. Circulating fibrocytes: collagensecreting cells of the peripheral blood. Int J Biochem Cell Biol 2004; 36:598-606.
19. Abe R, Donnelly SC, Peng T, et al. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 2001;166:7556-7562.
20. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994;331:1286-1292.
21. Border WA, Okuda S, Languino LR, et al. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature 1990;346:371-374.
22. Bottinger EP. Bitzer M. TGF-beta signaling in renal disease. J Am Soc Nephrol 2002;13:2600-2610.
23. Lan HY. Diverse roles of TGF-beta/Smads in renal fibrosis and inflammation. Int J Biol Sci 2011;7:1056-1067.
24. Latella G, Vetuschi A, Sferra R, et al. Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamineinduced hepatic fibrosis in mice. Liver Int 2009;29:997-1009.
25. Huang XR, Chung AC, Yang F, et al. Smad3 mediates cardiac inflammation and fibrosis in angiotensin II-induced hypertensive cardiac remodeling. Hypertension 2010;55:1165-1171.
26. Verrecchia F, Chu ML, Mauviel A. Identification of novel TGF-beta/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J Biol Chem 2001;276:17058-17062.
27. Sato M, Muragaki Y, Saika S, et al. Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest 2003;112: 1486-1494.
28. Zhao J, Shi W, Wang YL, et al. Smad3 deficiency attenuates bleomycininduced pulmonary fibrosis in mice. Am J Physiol Lung Cell Mol Physiol 2002;282:L585-L593.
29. Datto MB, Frederick JP, Pan L, et al. Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction. Mol Cell Biol 1999;19:2495-2504.
30. Yang J, Chen J, Yan J, et al. Effect of interleukin 6 deficiency on renal interstitial fibrosis. PLoS One 2012;7:e52415.
31. Xia Y, Entman ML, Wang Y. CCR2 regulates the uptake of bone marrowderived fibroblasts in renal fibrosis. PLoS One 2013;8:e77493.
32. Crawford JR, Pilling D, Gomer RH. Improved serum-free culture conditions for spleen-derived murine fibrocytes. J Immunol Methods 2010;363:9-20.
33. Hong KM, Belperio JA, Keane MP, et al. Differentiation of human circulating fibrocytes as mediated by transforming growth factor-beta and peroxisome proliferator-activated receptor gamma. J Biol Chem 2007;282:22910-22920.
34. Lebleu VS, Taduri G, O'Connell J, et al. Origin and function of myofibroblasts in kidney fibrosis. Nat Med 2013;19:1047-1053.
35. Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003;113:685-700.
36. Miyazono K. Positive and negative regulation of TGF-beta signaling. J Cell Sci 2000;113(Pt 7):1101-1109.
37. Roberts AB, Piek E, Bottinger EP, et al. Is Smad3 a major player in signal transduction pathways leading to fibrogenesis? Chest 2001;120 (Suppl):43S-47S.
38. Zhang G, Moorhead PJ, el Nahas AM. Myofibroblasts and the progression of experimental glomerulonephritis. Exp Nephrol 1995; 3:308-318.
39. Roberts IS, Burrows C, Shanks JH, et al. Interstitial myofibroblasts: predictors of progression in membranous nephropathy. J Clin Pathol 1997;50:123-127.
40. Essawy M, Soylemezoglu O, Muchaneta-Kubara EC, et al. Myofibroblasts and the progression of diabetic nephropathy. Nephrol Dial Transplant 1997;12:43-50.
41. Inazaki K, Kanamaru Y, Kojima Y, et al. Smad3 deficiency attenuates renal fibrosis, inflammation,and apoptosis after unilateral ureteral obstruction. Kidney Int 2004;66:597-604.